Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-04-03
1992-06-23
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 64, A61K 3170
Patent
active
051243172
ABSTRACT:
According to the invention there is provided a sterile, pyrogen-free, ready-to-use solution of an anthracycline glycoside, especially doxorubicin, which consists essentially of a physiologically acceptable salt of an anthracycline glycoside dissolved in a physiologically acceptable solvent therefor, which has not been reconstituted from a lyophilizate and which has a pH of from 2.5 to 6.5. The solution of the invention is particularly advantageous for the administration by injection of the anthracycline glycoside drugs, e.g. doxorubicin, in the treatment of both human and animal tumors.
REFERENCES:
patent: 4058519 (1977-11-01), Arcamone et al.
patent: 4075328 (1978-02-01), Ducep et al.
patent: 4250303 (1981-02-01), Wu et al.
patent: 4296105 (1981-10-01), Baurain et al.
patent: 4946831 (1990-08-01), Gatti et al.
Beneruto et al., American Journal of Hospital Pharmacy; vol. 38 (1981) pp. 1914-1918.
Beijnen et al., Pharmaceutisch Weekblad., Scientific Edition, vol. 7 (1985) pp. 109-116.
Arcamone et al., International Symposium on Adriamycin (1972) pp. 9-22.
Bosanquet, Cancer Chemother. Pharmacol. vol. 13 (1986) pp. 1-10.
English Translation of Official Action in Swedish Patent Application 8704849-2.
"Stability of Solutions of Antineoplastic Agents During Preparation and Storage for In Vitro Assays" by Andrew G. Bosanquet pp. 1-10.
English Translation of Official Action issued in German Application, 3741037.7.
English Translation of Official Action in Swedish Patent Application 8602743-0.
"Kinetics of the Acid-Catalyzed Hydrolysis of Doxorubicin" by Karsten Wassermann et al.; pp. 73-78.
"Martindale--The Extra Pharmacopoeia" Twenty-eighth Edition, Edited by James E. F. Reynolds.
"DOXORUBICIN" by Aristide Vigevani et al.; pp. 246-274.
"Termical Degradation of Adriamycin Hydrochloride Substance and Solutions of Various pH Were Examined, The Reaction Rate Constans, Temperature Factors and t.sub.10% Were Determined" by Teresa Kaniewska.
"Aspects of the Chemical Stability of Doxorubicin and Seven Other Anthracyclines in Acidic Solution" by J. H. Beijnen et al.; pp. 109-116.
Jornal of Parenteral Science and Technology, vol. 39, No. 6, 1985 pp. 220-222; by J. H. Beijnen et al.
The Merck Index, 10th Edition, 1983, p. 449, Edited by M. Windholz, et al.
"Physiological Principles of Pharmacy" by A. T. Florence, et al. Chemical Stability of Drugs, p. 475.
"The Merck Index" 10th Edition, by Martha Windholz, et al. published by Merck & Co., Inc. Rahway, N.J., U.S.A., 1983; p. 499.
The American Journal of Intravenous Therapy & Clinical Nutrition, pp. 15-18, Daniel Ketchum et al. 8, 15-18 (1981).
Dora and Fritz, Cancer Chemotherapy Handbook, Elsevier: New York, 1980, pp. 388-401.
Cancer Treatment Reports, vol. 65, No. 1-2, Jan./Feb. 1981 pp. 21-27, Edwin D. Savlov et al.
Cancer Treatment Reports, vol. 67, No. 2, Feb. 1983 pp. 133-142 Marc B. Garnick et al.
Journal of Pharmaceutical Sciences, pp. 782-785, Staffan Eksborg, Sep. 21, 1977 67.
Journal of Pharmaceutical Sciences, vol. 73, No. 6, Jun. 1984, pp. 766-770, Milena Menozzi et al.
Trissel, Handbook of Injectable Drugs, pp. 143, 144, 171 and 172.
Chemical Abstracts, vol. 92 (1980), 99512c.
Chemical Abstracts, vol. 94 (1981), 214489f.
Chemical Abstracts, vol. 99 (1983), 146022z.
Chemical Abstracts, vol. 101 (1984), 122451x.
Chemical Abstracts, vol. 102 (1985), 209266k.
Chemical Abstracts, vol. 104 (1986), 39716d.
Arzneimittel-Forschung, vol. 17 (1967), pp. 934-939.
The Merck Index (1983) pp. 3436.
Pharmaceutisch Weekbald, Scientific Edition, vol. 8, Apr. 25, 1986, pp. 109-133.
Journal of Chromatography 299 (1984), pp. 489-494.
Patent Abstracts of Japan (1956), 92212.
Martindale, The Extra Pharmacopoeia (1982), pp. 205-208.
Nor. Pharm. Acta, 45, 61-67 (1983).
J. Pharm. Biomed Anal., 2, 297-303 (1984).
Bottoni Giuseppe
Confalconieri Carlo
De Ponti Roberto
Gambini Luciano
Gatti Gaetano
Brown Johnnie R.
Farmitalia Carlo Erba S.p.A.
Peselev Elli
LandOfFree
Injectable ready-to-use solutions containing an antitumor anthra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable ready-to-use solutions containing an antitumor anthra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable ready-to-use solutions containing an antitumor anthra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-932904